Viewing Study NCT04880434


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2025-12-26 @ 5:28 PM
Study NCT ID: NCT04880434
Status: COMPLETED
Last Update Posted: 2025-11-17
First Post: 2021-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)
Sponsor: Kite, A Gilead Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module